To evaluate a multi-marker blood test for the accurate detection of endometriosis and its potential to identify cases missed by standard imaging.
Key Findings:
The blood test identified many histologically confirmed cases missed by ultrasound or MRI.
It maintained consistent performance across different phases of the menstrual cycle.
The assay integrates multiple biological processes reflecting the systemic nature of endometriosis.
Interpretation:
The findings suggest that a blood-based diagnostic approach could significantly reduce the time to diagnosis and reliance on invasive procedures, enabling earlier intervention for symptomatic patients.
Limitations:
Further validation in larger and more diverse populations is necessary.
Conclusion:
The study highlights the potential of integrated biomarker panels to enhance diagnostic accuracy and improve endometriosis care.
